Immunotherapy significantly improves overall survival for advanced NSCLC patients

FHS
July 7, 2023
3:13 am

A global study, led by UCL and UCLH and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer patients who were not able to be treated with platinum-containing chemotherapy, when compared to single-agent chemotherapy.

WHO and OHCHR launch guidance to reform legislation for ending coercive practices in mental health care

Ahead of World Mental Health Day, the World Health Organization (WHO) and the Office of the High Commissioner on Human Rights (OHCHR) are jointly launching

March 28, 2024

HIV patients have been less vaccinated with the full initial regimen against COVID-19

In December, the journal Vaccines published an analysis of COVID-19 vaccination coverage among people with HIV in Catalonia between December 2020 and July 2022.

February 5, 2024

CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth – Biotech Investments

EQS-News: CRS Clinical Research Services Management GmbH / Key word(s): Personnel CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and

April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.